bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
PATHRAPID01

Order Name:
Rapid Adequacy Assessment for FNA (Additional)

 
Useful For:
A diagnostic procedure used to investigate lumps or masses
 
Methodology:
Microscopy
 
 
 
Test Code:
PATHRAPID01

Order Name:
Rapid Adequacy Assessment for FNA (Additional)

 
Collection Specimen Or Container:
1. Fluid in Cytolyt solution or
2. Fluid in Preservcyte solution or
3. Slides in 95% alcohol fixative

*Please notify Surgical Pathology, Laboratory Department
(Tel.14146 or 14144) when planning to submit tissue for Rapid Adequacy Assessment for FNA
 
Specimen Testing Type:
1. Fluid in Cytolyt solution or
2. Fluid in Preservcyte solution or
3. Slides in 95% alcohol fixative

*Please notify Surgical Pathology, Laboratory Department
(Tel.14146 or 14144) when planning to submit tissue for Rapid Adequacy Assessment for FNA
 
Sub Mission Container:
1. Fluid in Cytolyt solution or
2. Fluid in Preservcyte solution or
3. Slides in 95% alcohol fixative

*Please notify Surgical Pathology, Laboratory Department
(Tel.14146 or 14144) when planning to submit tissue for Rapid Adequacy Assessment for FNA
 
Rejection Criteria:
Specimen in 10% neutral buffer formalin
 
Specimen Stabillity:
 
Specimen Type Temperature
Fluid Room temperature for fluid in cytolyt solution and preservcyt solution and slides in 95% alcohol fixative
 
 
 
Test Code:
PATHRAPID01

Order Name:
Rapid Adequacy Assessment for FNA (Additional)

 
Method detail:
Microscopy
 
Schedule:
Tested daily, at 07:00 am. - 06:00 pm.
 
Turnaround Time:
Received to Reported 15-30 mins by phone
 
Performing Location:
Surgical Pathology, Laboratory Department Tel.14146
 
Specimen Retention Time:
1 month after final report
 
 
 
Test Code:
PATHRAPID01

Order Name:
Rapid Adequacy Assessment for FNA (Additional)

 
 
Clinical Reference:
1. http://ltd.aruplab.com/Tests/Pub/2000443 (Retrieved: 1 Feb 2019) 2.https://en.wikipedia.org/wiki/Fine-needle_aspiration (Retrieved: 2 Feb 2019)